AAAAAA

   
Results: 1-7 |
Results: 7
CD34(-) CELLS INFLUENCE DAYS TO ENGRAFTMENT AND TRANSFUSION REQUIREMENTS IN AUTOLOGOUS BLOOD STEM-CELL RECIPIENTS()CD33()
Authors: PECORA AL PRETI RA GLEIM GW JENNIS A ZAHOS K CANTWELL S DORIA L ISAACS R GILLIO AP MICHELIS MA BROCHSTEIN JA
Citation: Al. Pecora et al., CD34(-) CELLS INFLUENCE DAYS TO ENGRAFTMENT AND TRANSFUSION REQUIREMENTS IN AUTOLOGOUS BLOOD STEM-CELL RECIPIENTS()CD33(), Journal of clinical oncology, 16(6), 1998, pp. 2093-2104
CYTOKINES FOR PRIMING AND MOBILIZATION OF PERIPHERAL-BLOOD PROGENITORCELLS (PBPC) IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY (HDC) WITHPERIPHERAL STEM-CELL TRANSPLANTATION (PSCT) - SEQUENTIAL ADMINISTRATION OF RHGM-CSF AND RHG-CSF VERSUS RHG-CSF ALONE
Authors: ISAACS RE JENNIS A ZAHOS K CANTWELL S ROSETI S DORIA L CORCORAN S MURPHY L WISNIEWSKI AM MICHELIS MA PECORA AL
Citation: Re. Isaacs et al., CYTOKINES FOR PRIMING AND MOBILIZATION OF PERIPHERAL-BLOOD PROGENITORCELLS (PBPC) IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY (HDC) WITHPERIPHERAL STEM-CELL TRANSPLANTATION (PSCT) - SEQUENTIAL ADMINISTRATION OF RHGM-CSF AND RHG-CSF VERSUS RHG-CSF ALONE, Blood, 88(10), 1996, pp. 3669-3669
DOSE-INTENSIVE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND PLATINUM (DICEP) AS APRIMING MOBILIZATION REGIMEN FOR PERIPHERAL-BLOOD STEM-CELL (PBSC) HARVESTING PRIOR TO HIGH-DOSE CHEMOTHERAPY (HDC)/
Authors: JENNIS A PECORA AL ISAACS RE CANTWELL S MICHELIS AM ZAHOS K
Citation: A. Jennis et al., DOSE-INTENSIVE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND PLATINUM (DICEP) AS APRIMING MOBILIZATION REGIMEN FOR PERIPHERAL-BLOOD STEM-CELL (PBSC) HARVESTING PRIOR TO HIGH-DOSE CHEMOTHERAPY (HDC)/, Blood, 88(10), 1996, pp. 1605-1605
TOTAL CD34- SUBSET PREDICT TIME TO NEUTROPHIL AND PLATELET ENGRAFTMENT AND HOSPITAL DISCHARGE IN PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY (HDC) WITH PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC)( CELL CONTENT AND CD34+CD33)
Authors: PECORA AL BROCHSTEIN JA JENNIS A MICHELIS M GRAZIOSO L ZAHOS K ISAACS RE
Citation: Al. Pecora et al., TOTAL CD34- SUBSET PREDICT TIME TO NEUTROPHIL AND PLATELET ENGRAFTMENT AND HOSPITAL DISCHARGE IN PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY (HDC) WITH PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC)( CELL CONTENT AND CD34+CD33), Blood, 84(10), 1994, pp. 10000088-10000088
AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOLLOWING BCNU, ETOPOSIDE, CYTARABINE AND CYCLOPHOSPHAMIDE (BVAC) FOR PATIENTS WITH RELAPSED LYMPHOMA
Authors: BROCHSTEIN JA PECORA AL ZAHOS K JENNIS A VANVLIET A GRAZIOSO L CANTWELL S MICHELIS M ISAACS R
Citation: Ja. Brochstein et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOLLOWING BCNU, ETOPOSIDE, CYTARABINE AND CYCLOPHOSPHAMIDE (BVAC) FOR PATIENTS WITH RELAPSED LYMPHOMA, Blood, 84(10), 1994, pp. 10000205-10000205
THE EFFECT OF PRIMED PERIPHERAL PROGENITOR CELLS (PPPC) ON HEMATOPOIETIC RECOVERY AND RESOURCE UTILIZATION IN AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT)
Authors: PECORA AL BROCHSTEIN JA ZAHOS K GRAZIOSO L VANVLIET A MICHELIS M
Citation: Al. Pecora et al., THE EFFECT OF PRIMED PERIPHERAL PROGENITOR CELLS (PPPC) ON HEMATOPOIETIC RECOVERY AND RESOURCE UTILIZATION IN AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT), Blood, 82(10), 1993, pp. 10000290-10000290
CARMUSTINE, ETOPOSIDE, CYTARABINE AND CYCLOPHOSPHAMIDE (BVAC) WITH AUTOLOGOUS STEM-CELL TRANSPLANT (SCT) FOR PATIENTS WITH CHEMOTHERAPY-SENSITIVE RELAPSED HODGKINS LYMPHOMA (HL) AND NON-HODGKINS-LYMPHOMA (NHL)
Authors: PECORA AL BROCHSTEIN JA VANVLIET A ZAHOS K
Citation: Al. Pecora et al., CARMUSTINE, ETOPOSIDE, CYTARABINE AND CYCLOPHOSPHAMIDE (BVAC) WITH AUTOLOGOUS STEM-CELL TRANSPLANT (SCT) FOR PATIENTS WITH CHEMOTHERAPY-SENSITIVE RELAPSED HODGKINS LYMPHOMA (HL) AND NON-HODGKINS-LYMPHOMA (NHL), Blood, 82(10), 1993, pp. 10000574-10000574
Risultati: 1-7 |